Watchlist Price Alert

Medifast Inc. (MED)

NYSE: MED · Real-Time Price · USD

12.95

0.00 (0.00%)

At close: May 08, 2025, 3:59 PM

12.92

-0.23%

After-hours: May 08, 2025, 05:56 PM EDT

0.00% (1D)

Bid	12
Market Cap	142.33M
Revenue (ttm)	543.45M
Net Income (ttm)	-7M
EPS (ttm)	-0.64
PE Ratio (ttm)	-20.23
Forward PE	-26.6
Analyst	Hold

Ask	13.46
Volume	200,004
Avg. Volume (20D)	235,752
Open	12.99
Previous Close	12.95
Day's Range	12.91 - 13.20
52-Week Range	11.57 - 27.16
Beta	0.98

About MED

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol MED

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MED stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Medifast has released their quartely earnings on Apr 28, 2025:

Revenue of $115.73M misses estimates by $672K, with -33.77% YoY decline.

EPS of -0.07 exceeds estimates by 0.18, with -110.61% YoY decline.

Why Price Moved

11 months ago

-8.14%

MEDIFAST shares are trading lower after DA Davidso... Unlock content with Pro Subscription

News

1 week ago · zacks.com

Medifast Q1 Loss Wider Than Expected, Sales Down 33.8% Y/Y

MED's first-quarter results show challenges from fewer active OPTAVIA Coaches. Nonetheless, the company is focusing on revitalizing its coach base for growth.

1 week ago · seekingalpha.com

Medifast, Inc. (MED) Q1 2025 Earnings Call Transcript

Medifast, Inc. (NYSE:MED ) Q1 2025 Earnings Conference Call April 28, 2025 4:30 PM ET Company Participants Steven Zenker - Vice President, Investor Relations Dan Chard - Chairman and CEO Jim Maloney -...

1 week ago · businesswire.com

Medifast Announces First Quarter 2025 Financial Results

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ...

2 weeks ago · zacks.com

Medifast to Report Q1 Earnings: What Investors Should Expect

MED's first-quarter results may show challenges in customer acquisition amid market headwinds and shifting consumer trends.

3 weeks ago · zacks.com

Medifast Trades Near 52-Week Low: What's the Best Move Now?

MED faces steep revenue declines and coach losses but aims to rebound through innovation, marketing and new GLP-1-focused initiatives.

1 month ago · seekingalpha.com

Medifast: GLP-1 Caused A Vicious MLM Flywheel Effect

Medifast, Inc.'s business is deteriorating as GLP-1 medication has lowered demand, causing a vicious flywheel effect as coaches are exiting the platform. The company is trying to reposition itself as ...

2 months ago · zacks.com

MED Q4 Earnings Beat, Revenues Dip Y/Y on Lower Customer Acquisition

Medifast's Q2 results show challenges related to weak customer acquisition. However, it is prioritizing efforts to enhance coach productivity in the near term.

2 months ago · seekingalpha.com

Medifast, Inc. (MED) Q4 2024 Earnings Call Transcript

Medifast, Inc. (NYSE:MED ) Q4 2024 Earnings Conference Call February 18, 2025 4:30 PM ET Company Participants Steven Zenker - Vice President, Investor Relations Dan Chard - Chairman and Chief Executiv...

2 months ago · zacks.com

Medifast (MED) Q4 Earnings and Revenues Beat Estimates

Medifast (MED) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of a loss of $0.27 per share. This compares to earnings of $1.09 per share a year ago.